This webinar covered
Targeted Protein Degradation continues to progress as a therapeutic area with huge potential, and 2023 is shaping up to be a landmark year for the degradation community. As we advance highly valuable degrader compounds closer to the clinic, we were thrilled to present to the community at the recent 3rd Targeted Protein Degradation Summit.
Offering the opportunity to explore the data delivered, this session provided a deep dive into the pipeline, including:
- An overview of the current TPD landscape
- A deep-dive into the oncology scope exploring preclinical and clinical indications
- Insights into the emerging non-oncology indications for novel degrader and stabilizer technologies